Literature DB >> 28139283

Advantages and limitations of online communities of patients for research on health products.

Sophie Ravoire1, Marie Lang2, Elena Perrin3.   

Abstract

The way patients and their caregivers share information on various online platforms about health topics and their own experiential knowledge presents new potential environments for research, particularly as concerns health products. The information provided individually and voluntarily by patients who are members of these online communities is a new resource for identifying and understanding precisely how health products are used, assessing their effectiveness, quantifying potential adverse effects in real-life situations, detecting subtle signs that are significant for experts in pharmacovigilance and addiction studies, and developing new assessment tools to help form new working hypotheses. How patients freely express their experiences and feelings and the reality of what they share also opens the way for societal research into health products, a field that is still under-explored. Well-established regulations govern research into health products, which uses resources and methodologies that have changed little over the years. However, the development of online communities of patients presents new possibilities in this field. The challenge we face today is defining their place among traditional research techniques. This place cannot be accepted by all stakeholders unless we first establish a firm understanding of the advantages, limitations, and constraints of these communities. The round table on this topic endeavoured to: explore these issues and develop a better understanding of the phenomenon and the different varieties of online communities and networks for patients; identify possible advantages, special features, and methodological, regulatory, and ethical limitations that researchers currently face; and finally, to put forward the first recommendations in this growing field of research.
Copyright © 2017 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Addiction vigilance; France; Online communities; Online data; Patients; Pharmacoepidemiology; Pharmacovigilance; Post-inscription; Research into health products; Social networks; Virtual communities

Mesh:

Year:  2017        PMID: 28139283     DOI: 10.1016/j.therap.2016.11.058

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  7 in total

1.  Knowledge Discovery from Posts in Online Health Communities Using Unified Medical Language System.

Authors:  Donghua Chen; Runtong Zhang; Kecheng Liu; Lei Hou
Journal:  Int J Environ Res Public Health       Date:  2018-06-19       Impact factor: 3.390

2.  Assessing patients' acceptance of their medication to reveal unmet needs: results from a large multi-diseases study using a patient online community.

Authors:  Jérémy Lambert; Michael Chekroun; Hélène Gilet; Catherine Acquadro; Benoit Arnould
Journal:  Health Qual Life Outcomes       Date:  2018-07-06       Impact factor: 3.186

3.  Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study.

Authors:  Atul T Patel; Theodore Wein; Laxman B Bahroo; Ophélie Wilczynski; Carl D Rios; Manuel Murie-Fernández
Journal:  JMIR Public Health Surveill       Date:  2020-12-07

4.  Patients' Perspectives About the Treatment They Receive for Cardiovascular Diseases and Mental Disorders: Web-Based Survey Study.

Authors:  Philippe Courtet; Catherine Pecout; Anne-Félice Lainé-Pellet; Michael Chekroun; Charlotte Avril; Jean-Jacques Mourad
Journal:  JMIR Form Res       Date:  2022-03-16

Review 5.  Framework and Practical Guidance for the Ethical Use of Electronic Methods for Communication With Participants in Medical Research.

Authors:  Atsushi Kogetsu; Kazuto Kato
Journal:  J Med Internet Res       Date:  2022-04-20       Impact factor: 7.076

6.  Immune-mediated inflammatory diseases and nutrition: results from an online survey on patients' practices and perceptions.

Authors:  Thao Pham; Harry Sokol; Bruno Halioua; Graziella Pourcel; Manuel Brun; Emilie Pain; Damien Testa
Journal:  BMC Nutr       Date:  2021-07-16

7.  Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK.

Authors:  Aude Roborel de Climens; Emilie Pain; Anders Boss; Alka Shaunik
Journal:  Diabetes Ther       Date:  2020-06-12       Impact factor: 2.945

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.